27.12.13 Flashcards

1
Q

Drug that should not be combined with zidovudine

A

ganciclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contraindication to zidovudine

A

Hb< 8 g%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Effect of rifampicin on AZT

A

increases the clearance of AZT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic admn of AZT is associated with

A

Lipodystrophy
Lipoatrophy
Nail hyperpigmentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Max chances of _________ and _________ are with didanosine

A

pancreatitis

diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hematological side effect of didanosine

A

neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adverse effects of didanosine

A

hyperuricemia
optic neuritis
painful sensory peripheral neuropathy
fulminant hepatic failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

most common cause of lipodystrophy amongst ART

A

stavudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

stavudine has the maximum chance of causing

A

lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

similar adverse effects of stavudine and didanosine

A

pancreatitis

peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Best tolerated NRTI

A

lamivudine

emtricitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

advantage of emtricitabine over lamivudine

A

once a day dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Least effective NRTI

A

zalcitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

side effect of zalcitabine

A

oral ulceration

stomatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Testing of which allele should be done before starting abacavir

A

HLA B*5701

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

abacavir increases the risk of

A

MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

all NRTI are excreted by kidney except

A

ABC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

abacavir is metabolised by

A

alcohol dehydrogenase

19
Q

Interaction of NRTI with food

A

food decreases oral bioavailability

20
Q

adverse effect of tenofovir

A

fanconi like syndrome with hypophosphatemia

21
Q

oral bioavailability of tenofovir is ____________ with meals

A

decreased

22
Q

side effect of tenofovir

A

flatulence

23
Q

ARTs active against hepatitis B

A

lamivudine
emtricitabine
tenofovir

24
Q

which drugs are selective for HIV 1

A

NNRTI(no effect against HIV 2)

25
Q

adverse effect of NNRTI

A

skin rash

26
Q

NNRTI avoided in pregnancy

A

efavirenz

delaviridine

27
Q

side effects of efavirenz

A

delusions
mania
vivid dreams

28
Q

2nd gen NNRTI

A

etravirine

rilpivirine

29
Q

ART that donot cause lipodystrophy

A

NNRTI

30
Q

effect of NNRTI on cyp450

A

nevirapine and efavirenz are inducers

delaviridine is an inhibitor

31
Q

adverse effects of indinavir

A

crystalluria

asymptomatic hyperbilirubinemia

32
Q

PI for which ritonavir boosting is not recommended

A

nelfinavir

33
Q

concentration of amprenavir and fosamprenavir decrease when co admn with

A

ethynyl estradiol

34
Q

PI effective against HIV resistant to other PI

A

tipranavir

35
Q

adverse effects of tipranavir

A

hepatotoxicty

ICH

36
Q

PI that does not cause lipodystrophy

A

atazanavir

37
Q

PIs causing asymptomatic hyperbilirubinemia

A

indinavir

atazanavir

38
Q

cardiac effect of atazanavir

A

PR prolongation

39
Q

atazanavir should not be given along with

A

proton pump inhibitors

40
Q

Atazanavir must be boosted with ritonavir when coadministered with

A

tenofovir and efavirenz

41
Q

ARTs that cause SJS

A

nevirapine

amprenavir

42
Q

drug that can be used to treat HIV associated lipodystrophy

A

tesamorelin

43
Q

mech of action of enfuviritide

A

binds to gp41 subunit of HIV

44
Q

drug used to boost the effect of elvitegravir

A

cobicistat